Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma, Kaposi 2HIV Infections 2Breast Neoplasms 1AIDS-Related Opportunistic Infections 1

Interventions

Zidovudine 9Doxorubicin 9Vincristine 6Bleomycin 6Interferon alpha-2 5Etoposide 5tecogalan 4Valganciclovir 4Semaxinib 4Liposomes 4Ritonavir 3Paclitaxel 3Nelfinavir 3Filgrastim 3Bevacizumab 3technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2sargramostim 2liposomal doxorubicin 2interferon alfa-n1 2Indinavir 2Docetaxel 2Didanosine 2Alitretinoin 2vesnarinone 1valspodar 1tocilizumab 1tin etiopurpurin 1pomalidomide 1pembrolizumab 1halofuginone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Sarcoma, Kaposi × Alitretinoin × Clear all
NCT00002188 2005-06-24

A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma

NIH AIDS Clinical Trials Information Service

Phase 2 Completed
27 enrolled
Sarcoma

Sarcoma, Kaposi, HIV Infections, AIDS-Related Opportunistic Infections

NCT00002439 2005-06-24

A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma

NIH AIDS Clinical Trials Information Service

Phase NA Completed
Sarcoma

Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡